
äœæ°ãªãããããªGPãèŠãŠãããšããªããæ ¢æ§è èç ãšããèšèã®æ¥æ¬èªèš³ãæ°ã«ãªã£ãŠãã話
ã«ãšã«ã®çããŸãããã¯éã®ãã€ã³ãªãâŠïŒ
ããããã飯ã®ããããšé貚ãçãéšŸéŠ¬ãšæ£æ£è¢ããåºãâŠïŒ
ãåæã®å€ãäŒæ¥ã«ãé¢ãããç·æ¥æè¡ã«åŒã³åºãããåŸã®ãç§ã®ç²åŽå°æã®è³ãäžæã§èŠéãããå¥åŠãªç«¥è©±ã®ã¿ã€ãã«ã
ããžãã¬ãç³»ãã©ãšãã£ãŒãèžèœäººãæ¬æ°ã§èããïŒããããªGPãã®ãããµãã³äŒç»ã§ç»å Žããã童話ã®é¡åéãªã®ã ã
ãã«ãšã«ã®çããŸãããã¯éã®ãã€ã³ãªããããã®çŽèš³èª¿ã¿ã€ãã«ã¯ãåé¡ Der Froschkönig oder der eiserne Heinrich ã®åèªãæ©æ¢°çã«ã€ãªããã ãã ã
ç¶ããããããã飯ã®ããããšé貚ãçãéšŸéŠ¬ãšæ£æ£è¢ããåºãããããã€ãèªã¿ã€ãã«ãã»ãŒéèªã§äžŠã¹ãçµæã§ããããã¯ãæ©å£èšèã®åã ã
ç¬ãã蟌ã¿äžããäžæ¹ã§ã
ãæå³ãã©ããã«çœ®ãå»ãã«ããã翻蚳ã¯ãå»ççŸå Žã«ãæœãã§ããã®ã§ã¯ãªããã
ãšããç念ãèžãåºããã
ã童話ã®ã¿ã€ãã«çšåºŠãªãç¬ãè©±ã§æžãã
ãããå»ççšèªãšãªãã°ã翻蚳ã®ã»ããã³ã¯èšºçã®é
å»¶ã誀解ãåŒã³ãããªãã
ç§ã¯ãå®çŸ©ã誀解ãããã¡ãªãäºã€ã®ä»£è¡šçãªå»åŠçšèªãæãäžããŠã¿ãããšã«ããã
â ¡ Circulatory ShockïŒãµãŒãã¥ã©ããªãŒã»ã·ã§ãã¯ïŒåŸªç°æ§ã·ã§ãã¯ïŒ
1. ããšã°ãšç æ âãé©ããã§ã¯ãªã
ãŸããæ£è ãããžã®ç ç¶èª¬æã®æã誀解ãæããããèšèNo.1ãã·ã§ãã¯ã§ãããææ¥å»ã䜿ããã¡ãªèšèã ã
æ¥åžžã®ãã·ã§ãã¯ãã¯âã³ã£ããâã®æ¯å©ã ããå»åŠã§ãã Circulatory Shock ã¯ãååãªè¡æ¶²ãèåšã«å±ãããå
šèº«ã®çްèãèåšãžã®é
žçŽ äŸçµŠãäžè¶³ããé
žçŽ é絊ãã©ã³ã¹ãç Žç¶»ããç·æ¥ã®ç¶æ
ããæã (3)ã
ããšãããªããéœåžïŒèåšïŒãžç©è³ãéã¶é«ééè·¯ïŒè¡ç®¡ïŒãäžæå°éããããããæ°ååã§è¡ãåé»ã»ææ°Žããã€ã¡ãŒãžã ã
å¿èãæ¢ãŸãâå¿åæ¢âãšã¯å¥ã§ãè¡å§ãäžãããããããšã§å šèº«ãžã®è¡æµåŸªç°ãäžååãšãªãã现èãé žæ¬ ãžåããããã»ã¹ã§ããã
ã·ã§ãã¯ã®èª¬æã¯ããªããªãäŒããã¥ããããæ ¹æ°ããäžèšã®ãããªäŸãçšããŠæ®æ®µã¯èª¬æã詊ã¿ãŠããã
âShock is a life-threatening, generalized form of acute circulatory failure associated with inadequate oxygen utilization by the cells.â
ã·ã§ãã¯ãšã¯ã现èãå¿ èŠãšããé žçŽ ãå©çšã§ããªããªãå šèº«æ§ã®æ¥æ§åŸªç°äžå šã§ãããçåœãè ãã屿©çç¶æ ãæãã
2. åã€ã®åãèŠåããââåºè¡æ§ã»å¿åæ§ã»é塿§ã»è¡æ¶²ååžç°åžžæ§
æ¥æ¬ææ¥å»åŠäŒã§ã¯ããã®ã·ã§ãã¯ãåå ããšã«æ²»çæ¹éãæŽçãã (4)âã
åºè¡æ§ã·ã§ãã¯ïŒäºæ ãæè¡ã§å€§éåºè¡ã察çã¯â倱ã£ãè¡ãæ¢ããŠãå ¥ããŠæ»ãâããšã
茞è¡ãšåæã«30 mL/kg ã®èŒžæ¶²ã§è¡ç®¡ãæºãããæ¢è¡æè¡ãžèµ°ãã
å¿åæ§ã·ã§ãã¯ïŒå¿çæ¢å¡ãªã©ã§ãã³ãæ©èœãäžå šã«é¥ãç¶æ ã匷å¿è¬ãæ©æã«ããŒãã«æ²»çãéµã
é塿§ã·ã§ãã¯ïŒå¿ã¿ã³ãããŒããèºå¡æ ã§è¡æµè·¯ãç©ççã«è©°ãŸããåå é€å»ãéèŠã
è¡æ¶²ååžç°åžžæ§ã·ã§ãã¯ïŒæè¡çãã¢ããã£ã©ãã·ãŒã§è¡ç®¡ãæ¡åŒµããè¡å§ãæ¯ããããªããè¡ç®¡åçž®è¬ãã¯ãããšããã«ãã³ã©ãã³ã®æäžãèããã
3. ãªãèšãæããèŠãã®ã
ãã¬ãã SNS ã«èºããââã§ã·ã§ãã¯ïŒãã®è»œãçšæ³ã¯ãå®¶æãžç¶æ ã説æãããšãæ··ä¹±ãæããèšèãæ£ç¢ºã«æ£è ããã«äŒããã°ãæ²»çã®åªå é äœãæ£è ãããžã®ã®çè§£ãäžèŽããããã
â ¢ SepsisïŒã»ãã·ã¹ïŒæè¡çïŒ
1. Sepsis-3âãææãè¡ã«ä¹ããã§ã¯ãªããå šèº«ãæŽèµ°ãã(é害ãããã)ã
ãæã¯è¡å¹éœæ§ïŒèãè¡æ¶²ã«åºãïŒïŒæè¡çãšããå®çŸ©ãåºãã£ãŠããã
ããã¯ãsepsisã®èš³ã«èµ·å ãããšãããããèšèã®å®çŸ©ãã®ãã®ãææ§ãªåœ¢ã§æ¥æ¬äººãèš³ããããšã§ãèè¡çãšãããã¥ã¢ã³ã¹ã匷ãã£ãã®ã ããã
ããã 2016 幎ã®ã¬ã€ãã©ã€ã³ã§ã¯ãSepsis-3 ãšããæ°ããªå®çŸ©ãæå±ãã ãæè¡çã¯ãææã«ããå¶åŸ¡äžèœãªå ç«åå¿ãèåšé害ãèµ·ããç¶æ ããšäœçœ®ã¥ããã(6)âã
ææã®å Žæã¯èºã§ãè ¹è ã§ããããè¡æ¶²ã«èãåºãªããŠãèåšé害ãè©äŸ¡ããã¹ã³ã¢ãªã³ã°SOFAã2ç¹ä»¥äžã§ããã°æè¡çã ã
âSepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection.â
æè¡çãšã¯ãææçã«å¯Ÿããå¶åŸ¡äžèœãªå®¿äž»åå¿ã«ãã£ãŠçããçåœãè ããèåšé害ã§ãããïŒèåšéå®³ã®ææšãšã㊠SOFA ã¹ã³ã¢ 2 ç¹ä»¥äžã®å¢å ãçšããïŒ
2 翻蚳ã®ã£ãããšçŸå Ž
ã¬ã€ãã©ã€ã³ã¯ âSepsis â Bacteremiaâ ãšç¹°ãè¿ãããçšèªæŽçãããªããã°çŸå Žã®æèã¯å€ãããªãã
ããããæè¡çãšããèš³ã¯ããªããªãææçã«èµ·å ããç æ ã ãšæ¥æ¬èªã§ãããã«ããã®ãåé¡ã ããã
æè¡çãšããèšèãæ®åãããããæ¥æ¬ã¯ãã¡ããäžçã§ãåçºæŽ»åã¯ç¶ãã
â £ Heart FailureïŒããŒãã»ãã§ã€ãªã¢ãŒïŒå¿äžå šïŒ
1. ç æ°ã®ã€ã¡ãŒãžãšçŸå®
ãå¿äžå
šããšèããšâå¿èãå£ããŠåããªãâå°è±¡ãæã€äººãå€ãã
å¿åæ¢ãšèª€è§£ããããããšãæ¥ã
æ£è
ããã«èª¬æããŠããŠæããçšèªã ã
ã ãå®éã¯ãé«è¡å§ã»ç³å°¿ç ãªã©ã§åŸã ã«ãã³ãåãèœã¡ãäœå ã«è¡æ¶²ãæžæ»ããããšã§èº«äœã®é害ããããâçå矀âãšããŠã®èªèãæ£ããã
åœå ã¬ã€ãã©ã€ã³ã§ã®æ£ããå®çŸ©ã¯ã以äžã®ãããªãã®ã§ããã
âHeart failure is a clinical syndrome with current or prior symptoms ± signs caused by a structural and/or functional cardiac abnormality, corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion.â
å¿äžå šãšã¯ãå¿èã®æ§é çãŸãã¯æ©èœçç°åžžã«èµ·å ããŠãçŸåšãŸãã¯éå»ã«çç¶ããã³ïŒãŸãã¯å åãåããããããªãŠã å©å°¿ããããã®äžæãããã³ïŒãŸãã¯ãèºãã£è¡ã»å šèº«ãã£è¡ã®å®¢èгçæèŠãã§è£ã¥ããããèšåºçå矀ã§ããã
ãã·ã¥ç€Ÿã® 2025 幎調æ»ã§ã¯ãå¿äžå šãæ£ç¢ºã«èª¬æã§ããã®ã¯ 9.7 %ãå¿äžå šè¡æ¶²æ€æ»ã®èªç¥ã¯ 6 % ã«çãŸã£ã (10)âã
2. âå¿äžå šïŒæ»ã®å®£åâ ãé²ãèšè
ã¡ãã£ã¢ã®èšå ±èŠåºããå¿äžå
šã§æ»å»ãã¯ããããã峿»ç
åã®ãããªèª€è§£ãå©é·ãããå»åž«ãæ»äº¡èšºææžã«ãå¿äžå
šãšèšèŒããããšã¯äžé©åã§ãããšãããŠããã
åœç«åœèªç ç©¶æã¯ãæ
¢æ§å¿äžå
šïŒå¿èã®æ©èœã匱ãé·æã®ç
æ°ïŒããšè£è¶³ããèšãæãäŸãæ²èŒããæ©æå蚺ãä¿ããŠãã (13)âã
ãããããªããªãäžè¬ã®æ¹ã«äŒããã«ããå»ççšèªã®äžã€ãšèšããã ããã
â € DeliriumïŒããªãªãŠã ïŒããåŠïŒ
1. âããåŠâ ã®ã€ã¡ãŒãžãšã®ã£ãã
Delirium ã¯æ¥æ§ã®æ³šæéå®³ïŒæèå€å®¹ãæ¬è³ªã
ãšãããéŠèš³ãããåŠãã¯åŠæ³ã»å¹»èŠã®èªæã匷ããå¯ãããã§å£°ãåºããªãâäœæŽ»ååâãèŠéãããã (14)ã
ããã¯èªç¥çãšã®éããèªæºãã説æãããšçè§£ãããããDelirium ã¯ã©ãã³èª âde liraâïŒçã®çããå€ããïŒãç±æ¥ã§âçªçºçã«ã³ãŒã¹ã¢ãŠãããâã€ã¡ãŒãžã ã
âDelirium is a disturbance in attention and awareness that develops over a short period of time, represents an acute change from baseline, fluctuates in severity, and is accompanied by an additional disturbance in cognition.â
ããåŠãšã¯ã泚æãšæèã®é害ãçæéã§åºçŸããæ¥å ã§å€åãããã€èªç¥æ©èœé害ãäŒŽãæ¥æ§è³æ©èœäžå šã§ããã
2. èŠéãããããã転垰
ãããç ç©¶ã§ã¯ãããåŠãåããé«éœ¢æ£è
ã¯åšé¢æ»äº¡ã 2 åãéé¢åŸ 1 幎ã®èªç¥æ©èœäœäžçã 3 åã«äžã£ã (16)âã
æ©æçºèŠã§ãªã¹ã¯ãäžãããããšåãã£ãŠãã以äžãèšèã®èª€è§£ã¯åãé€ããªããã°ãªããªãã ããã
â ¥ Chronic Kidney DiseaseïŒã¯ãããã¯ã»ããããŒã»ãã£ãžãŒãºïŒæ ¢æ§è èç ïŒ
1. âCKDâ ãšããèšèã¯ãã°ãã°å»çåŸäºè ãè¬ã£ãæ¥æ¬èªã§èš³ããŠããŸã
2000幎代åé ãŸã§ãæ¥æ¬ã§ã¯è æ©èœã®æ ¢æ§äœäžãç·ç§°ããŠãæ ¢æ§è äžå šããšåŒã³ãæ«æïŒeGFR30 mL/åæªæºïŒã«çŠç¹ãåœãã£ãŠãããã«ã³ãã¡ã¬ã³ã¹ã§ããææããŸã ã«æ ¢æ§è äžå šãšããåèªãè¡ã亀ãããšãããã
2002幎ãç±³åœè èè²¡å£ K/DOQI ãæ©æéå®³ãæŸãäžããç®çã§ Chronic Kidney DiseaseïŒCKDïŒ ãæå±ããå®çŸ©ããåå ãåãã eGFR < 60 ãŸãã¯è é害ãïŒãææç¶ãã«æ¡åŒµãã ã
ãã®æ°æŠå¿µãåããæ¥æ¬è èåŠäŒã¯2004幎ã«CKD察çå§å¡äŒãèšçœ®ã2007幎ã«åçãCKD蚺çã¬ã€ããã§èš³èªããæ ¢æ§è èç ããšå®ããã
åç§°å€æŽã«ãããäžè¬å ç§å»ã«ãæ©æçºèŠã»çæŽ»ç¿æ £ä»å ¥ã®éèŠæ§ã浞éããçŸåšã§ã¯ãæ ¢æ§è äžå šãã¯æ«ææ®µéïŒã¹ããŒãžG5ïŒã®ã¿ãæãçšèªãšããŠæŽçãããŠããã
å¥èšºçµæã« eGFR < 60 ãš âCKD ã¹ããŒãž3aâ ãšæžãããŠããŠããå€ãã®äººã¯æå³ãããããªããåæµ·éäœæ° 2,000 人調æ»ã§ã¯ãCKD ã説æã§ãããå²å㯠2.8 % ã«ãšã©ãŸã£ã (17)âã
âCKD is defined as kidney damage or a decreased glomerular filtration rate of < 60 mL/min/1.73 m² for at least 3 months, irrespective of cause.â
CKD ãšã¯ãè é害ã®ååšãŸã㯠GFR < 60 mL/å/1.73 m² ã3 ãæä»¥äžæç¶ããç¶æ ïŒåå ãåããïŒãããã
2. ããããããèšãæã
åœèªç ç©¶æã®ææ¡ã¯ãæ ¢æ§è èç ïŒè èã®æ ¢æ§çãªãã¡ãŒãžã§åããèœã¡ãç æ°ïŒããšããäºé衚èšãå»é¢ã®åŸ åæ²ç€ºãã³ãã¬ãŒããå ¬éãããå»çè ãã³ããŒããŠäœ¿ããããã«ãªã£ãŠããã (19)ãå°ããããã«ãããšæããã®ã¯èªåã ãã ãããâŠâã
â § ãããã«
童話ã®ãžããŠããªéŠé¡ãæãã¬æ°ã¥ãããããã翻蚳ã®ãããã
ããã¯ãå»çç³»ã®äžçã§ãèµ·ããåŸããããã§ããããšã«éããªãã
ç§ã¯ãã¡ã¹ã®åãå³ãšåãããã«ãèšèã®è¡šçŸã粟床ãå»åž«ã¯ç£šãç¶ããå¿
èŠããããšæãã
ããŸãèšãæãããæèš³ã®ã§ãããèšèãå·§ã¿ã«æ±ããå»è
ã«ãªããããã®ã ã
ããªãã¡è±èªã𿥿¬èªã®æŠå¿µããŽãããšåã¿åãå»çããåã«é¡ãã
æåŸãŸã§èšäºãèªãã§ããã ãæ¬åœã«ããããšãããããŸãã
ä»åŸãå»åž«ãå»çã®èŠç¹ããæ¥ã
æããããšãå¿ã蟌ããŠç¶ŽããŸãã
çããã®æ¯æ¥ã«åœ©ãããããããããäœãæ¥åžžãçæŽ»ã«ã€ããŠèãããã£ããã«ãªãèšäºãäœã£ãŠåããŸãã®ã§ããããããã°ã¹ãããã©ããŒããã ãããšå¬ããã§ãã
ã¯ã³ã³ã®ããã«æããŠåã³ãŸãã
åŒçšæç®
(1) ããžãã¬ããèžèœäººãæ¬æ°ã§èããïŒããããªGPãå
¬åŒ https://www.fujitv.co.jp/dokkirigp/ hos.akita-u.ac.jp
(2) Grimm Stories 翻蚳è蚌 https://grimmstories.com/jp/grimm_fairy-tales/the_frog_king Jaam
(3) æ¥æ¬ææ¥å»åŠäŒ çšèªè§£èª¬é https://www.jaam.jp/ æ¥æ¬è
èåŠäŒ
(4) æ¥æ¬ææ¥å»åŠäŒ åŸªç°æ§ã·ã§ãã¯ã¢ã«ãŽãªãºã 2023 https://jaam.jp/algorithms/shock2023.pdf ãµã€ãšã³ã¹ãã€ã¬ã¯ã
(5) åœç«åœèªç ç©¶æãç
é¢ã®èšèãæçµå ±å https://www2.ninjal.ac.jp/byoin/pdf/byoin_teian200903.pdf ãžã£ããããã¯ãŒã¯
(6) JAMA Network Sepsis-3 å®çŸ© https://jamanetwork.com/journals/jama/fullarticle/2492881 ãžã£ããããã¯ãŒã¯
(7) æ¥æ¬çæè¡ç蚺çã¬ã€ãã©ã€ã³ 2024 PDF https://onlinelibrary.wiley.com/pb-assets/assets/18833772/jja2s0025_JAAM.pdf Wiley Online Library
(8) J-SSCG2024 CQ3-3 å¹³ååèå§ PDF https://www.jaam.jp/info/2023/files/20231122_WG3.pdf Jaam
(9) æ§çæè¡çã¬ã€ãã©ã€ã³è§£èª¬ PDF https://www.jsicm.org/pdf/jjsicm28Suppl.pdf æ¥æ¬éäžæ²»çå»åŠäŒ
(10) ãã·ã¥ã»ãã€ã¢ã°ãã¹ãã£ãã¯ã¹ å¿äžå
šæèèª¿æ» https://www.roche-diagnostics.jp/media/releases/2025-3-11 ãã·ã¥ãã€ã¢ã°ãã¹ãã£ãã¯ã¹
(11) JCS/JHFS 2025 å¿äžå
šèšºçã¬ã€ãã©ã€ã³ https://www.j-circ.or.jp/cms/wp-content/uploads/2025/03/JCS2025_Kato.pdf äžè¬ç€Ÿå£æ³äºº æ¥æ¬åŸªç°åšåŠäŒ
(12) æ¥æ¬åŸªç°åšåŠäŒ ã¬ã€ãã©ã€ã³ã·ãªãŒãº https://www.j-circ.or.jp/guideline/guideline-series/ äžè¬ç€Ÿå£æ³äºº æ¥æ¬åŸªç°åšåŠäŒ
(13) åœèªç ç
é¢ã®èšèãããããããïŒè£è¶³äŸïŒ https://www2.ninjal.ac.jp/byoin/teian/pdf/index.html ã«ãããã
(14) J-Stage ããåŠçšèªèª¿æ» https://www.jstage.jst.go.jp/article/jaamkanto/45/4/45_211/_pdf ãµã€ãšã³ã¹ãã€ã¬ã¯ã
(15) ããåŠèšºçã¬ã€ãã©ã€ã³ 2023 PDF https://jpos-society.org/pdf/gl/2023delirium/all_2023-guideline-delirium.pdf
(16) Outcomes after Delirium in Japanese ICU https://www.sciencedirect.com/science/article/abs/pii/S0163834314002205 ãµã€ãšã³ã¹ãã€ã¬ã¯ã
(17) åæµ·é CKD èªç¥åºŠèª¿æ»ïŒHGPIïŒ https://hgpi.org/lecture/column-55.html æ¥æ¬ãµã€ã³ãªã³ã³ããžãŒåŠäŒ
(18) æ¥æ¬è
èåŠäŒ CKD ã¬ã€ãã©ã€ã³ 2023 PDF https://jsn.or.jp/medic/guideline/pdf/guide/viewer.html?file=001-294.pdf æ¥æ¬è
èåŠäŒ
(19) åœèªç ç
é¢ã®èšèïŒæ²ç€ºãã³ãã¬ãŒãïŒ https://www2.ninjal.ac.jp/byoin/teian/pdf/index.html ã«ãããã